Max Reinhardt - Oct 7, 2022 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
President, Rest of World
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Oct 7, 2022
Transactions value $
-$80,040
Form type
4
Date filed
10/11/2022, 04:13 PM
Previous filing
Jun 8, 2022
Next filing
Jun 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale -$80K -1.38K -4.21% $58.00 31.4K Oct 7, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
F2 Includes 408 shares of common stock acquired under the issuer's employee stock purchase plan in June 2022.